NCT02607722View on ClinicalTrials.gov

All-Case Surveillance of Ofev in Patients With IPF in Japan

CompletedOBSERVATIONAL
Enrollment

10,117

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

May 2, 2023

Study Completion Date

May 2, 2023

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Nintedanib

Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY